Search
for
Sort by
Research 781–810 of 1000+
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Fetal alpha 5-reductase Val89Leu mutation is associated with late miscarriage
- Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional study
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland
- Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database
- Prevalence of thyroid dysfunction in patients with systemic lupus erythematosus: A descriptive cross sectional study
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- The prevalence of hair loss and its association with iron deficiency among adolescents in northern Sudan: a school-based cross-sectional study.
- The prevalence of hair loss and its association with iron deficiency among adolescents in northern Sudan: a school-based cross-sectional study.
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- 0348 Adverse event reports of alopecia for sunscreen ingredients and branded products
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Unhealthy diet and lifestyle factors linked to female androgenetic alopecia: a community-based study from Jidong study, China
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Genetic Association Between Polycystic Ovary Syndrome and the <i>APOA5</i> rs662799 and <i>PLIN1</i> rs894160 Metabolic Variants in the Western Saudi Population: A Case-Control Study
- Characterization of Polycystic Ovary Syndrome Among Flo App Users Around the World
- RADIATION-INDUCED ALOPECIA: A SYSTEMATIC REVIEW OF INCIDENCE, RISK FACTORS, PREVENTION, AND MANAGEMENT
- Patterns of Sensitization and Cross-Reactivity in Hair Dye Allergy: An 18-Year Tertiary-Center Experience from Greece.
- Causal Relationship Between Gut Microbiota and Androgenic Alopecia: A Mendelian Randomization Analysis
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- 202 Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanoma
- Association between iron deficiency and telogen effluvium: a systematic review and meta- analysis
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- PD20-08 INVESTIGATION OF SEXUAL DYSFUNCTION LINKED TO FINASTERIDE USE: A PHARMACOVIGILANCE ANALYSIS